The global antiviral drug market is estimated to grow at a CAGR of over 4% during the forecast period. Increasing viral infections such as Human immune deficiency virus (HIV), influenza A & B, hepatitis B & C, herpes, chickenpox, and papilloma, among others is the major driving factor of the global antiviral drug market. HIV is among one of the major viral infectious disease. According to the World Health Organization (WHO), HIV has claimed over 32 million lives and 37.9 million people are living with HIV in 2018. One of the chronic viral diseases is Hepatitis B. According to data published by WHO, in 2015, an estimated 257 million people were living with Hepatitis B, and it caused the death of over 8,87,000 people. Moreover, a large amount of investment in this sector is also driving the market. For instance, as per the new study by WHO, 67 low- and middle-income countries invest $6 billion per year for eliminating hepatitis.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/antiviral-drug-market

Patients with viral disease, such as HIV, influenza A & B, hepatitis B & C, herpes and so on are treated with antiviral drugs. Antiviral drugs can be used for the treatment of a broad range of virus affected diseases. Much biological company’s R&D on drugs for the treatment of human immune deficiency virus (HIV) infection are in the pipeline. Moreover, recent pandemic Corona (COVID-19) infection treatment’s R&D on its drugs are also in the pipeline. However, high costs involved in R&D,demand for alternative medicines such as naturopathy and homeopathy, huge time effort in R&D and sometimes it slow success rate of treatment are some factors that are restraining market growth.

Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/antiviral-drug-market

Moreover, competitive market and frequent fluctuation drug prices, lack of safety awareness about infections among the public are also restraining the market growth. Although, increasing awareness among the people in both rural and urban areas about viral infections and its treatment is one of the major opportunities of the global antiviral drug market. For instance, according to WHO,in 2016, an estimated 10.5% of all Hepatitis B infected people were aware of their disease and among them, 16.7% of people diagnosed were on treatment.

Market Segmentation

Global Antiviral Drug Market by Application
Influenza (Flu) Antiviral Drugs
Hepatitis Antiviral Drugs
HIV Antiviral Drugs
Herpes Antiviral Drugs
Others
Global Antiviral Drug Market by Type
Branded
Generic
Regional Analysis

North America
US
Canada
Europe
UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
Company Profiles

AbbVie, Inc.
Arbutus Biopharma Corp.
Aurobindo Pharma, Ltd.
BioCryst Pharmaceuticals, Inc.
Bristol-Myers Squibb Co.
Cipla, Inc.
Dr. Reddy’s Laboratories, Ltd.
F. Hoffmann-La Roche AG
Gilead Sciences, Inc.
GlaxoSmithKline PLC
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Pfizer, Inc.
Sanofi S.A.
Sino Biopharmaceutical, Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/antiviral-drug-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari

Email: [email protected]
Contact no: +91 780-304-0404